KMT2A (previously known as MLL) rearrangements occur in up to 80% of acute lymphoblastic leukaemia (ALL) and 50% of AML in infants, compared with 5% and 15% of older children, respectively [22]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.